Elizabeth Martinez

499 total citations
38 papers, 329 citations indexed

About

Elizabeth Martinez is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Elizabeth Martinez has authored 38 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 7 papers in Genetics. Recurrent topics in Elizabeth Martinez's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Elizabeth Martinez is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Elizabeth Martinez collaborates with scholars based in United States, Colombia and Germany. Elizabeth Martinez's co-authors include Reinhard von Roemeling, Carmen R. Valdez, Mary Beth Wire, Yu Lou, Craig W. Hendrix, George E. Bigelow, Edward J. Fuchs, Carl Leukefeld, Eric S. Winer and Aristoteles Giagounidis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Critical Care Medicine.

In The Last Decade

Elizabeth Martinez

37 papers receiving 305 citations

Peers

Elizabeth Martinez
Kate Reed United Kingdom
Mark Duncan United States
Rebecca Kaufman United States
Kathleen McDermott United States
Jun Hyung Kim South Korea
Lisa L. Wood United States
Deborah Richardson United Kingdom
Robert J. Johnson United States
Ashley Perry United States
Kate Reed United Kingdom
Elizabeth Martinez
Citations per year, relative to Elizabeth Martinez Elizabeth Martinez (= 1×) peers Kate Reed

Countries citing papers authored by Elizabeth Martinez

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Martinez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Martinez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Martinez more than expected).

Fields of papers citing papers by Elizabeth Martinez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Martinez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Martinez. The network helps show where Elizabeth Martinez may publish in the future.

Co-authorship network of co-authors of Elizabeth Martinez

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Martinez. A scholar is included among the top collaborators of Elizabeth Martinez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Martinez. Elizabeth Martinez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Martinez, Elizabeth, et al.. (2023). Long-Term Effects of Degradation on Photovoltaic System Return on Investment. IEEE Latin America Transactions. 21(12). 1282–1290. 2 indexed citations
3.
Martinez, Elizabeth, et al.. (2023). Hyperspectral camera as a compact payload architecture for remote sensing applications. Applied Optics. 62(8). C88–C88. 4 indexed citations
4.
Guidetti, Francesca, Alberto J. Arribas, Giulio Sartori, et al.. (2023). Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of Clinical Medicine. 12(2). 399–399. 10 indexed citations
5.
Mullan, Paul C., et al.. (2023). Reducing physical restraints in pediatrics: A quality improvement mixed-methods analysis of implementing a clinical debriefing process after behavioural health emergencies in a Children's Hospital. Current problems in pediatric and adolescent health care. 53(9). 101463–101463. 2 indexed citations
7.
Garcia‐Manero, Guillermo, Eric S. Winer, Daniel J. DeAngelo, et al.. (2022). Phase 1/2a study of the IRAK4 inhibitor CA-4948 as monotherapy or in combination with azacitidine or venetoclax in patients with relapsed/refractory (R/R) acute myeloid leukemia or lyelodysplastic syndrome.. Journal of Clinical Oncology. 40(16_suppl). 7016–7016. 30 indexed citations
8.
Landsburg, Daniel J., Stefan K. Barta, Radhakrishnan Ramchandren, et al.. (2021). Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses. British Journal of Haematology. 195(2). 201–209. 30 indexed citations
9.
Guidetti, Francesca, Alberto J. Arribas, Filippo Spriano, et al.. (2021). Abstract P073: Pharmacological inhibition of IRAK4 with CA-4948 is beneficial in marginal zone lymphoma models with secondary resistance to PI3K and BTK inhibitors. Molecular Cancer Therapeutics. 20(12_Supplement). P073–P073. 1 indexed citations
10.
Martinez, Elizabeth, et al.. (2021). Improving Equity of Care for Patients with Limited English Proficiency Using Quality Improvement Methodology. Pediatric Quality and Safety. 6(6). e486–e486. 10 indexed citations
11.
Martinez, Elizabeth. (2021). Designing a Clarifier to Recover Wastewater Algae Biomass for Production of Biofuels. Digital Commons - USU (Utah State University). 1 indexed citations
12.
Martinez, Elizabeth, et al.. (2020). 392 Phase 1 study of CI-8993 anti-VISTA antibody in patients with advanced solid tumor malignancies. Regular and Young Investigator Award Abstracts. A238–A239. 11 indexed citations
13.
Martinez, Elizabeth, et al.. (2020). MRI Brain Tumour Segmentation using a CNN Over a Multi-parametric Feature Extraction. 2. 1–6. 3 indexed citations
15.
Michelson, Kelly N., Karen Rychlik, Jody D. Ciolino, et al.. (2017). 867: A RANDOMIZED TRIAL IN THE PICU COMPARING A COMMUNICATION INTERVENTION WITH AN INFORMATIONAL BROCHURE. Critical Care Medicine. 46(1). 418–418. 1 indexed citations
16.
Martinez, Elizabeth, et al.. (2013). Latino parents and teachers: key players building neighborhood social capital. Teaching Education. 24(2). 195–208. 7 indexed citations
17.
Martinez, Elizabeth, et al.. (2010). Assessing Dyspnea in Patients With Non-Small Cell Lung Cancer in the Acute Care Setting. Clinical journal of oncology nursing. 14(4). 509–513. 8 indexed citations
18.
Cao, Ying‐Jun, Patrick F. Smith, Mary Beth Wire, et al.. (2008). Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Fosamprenavir‐Ritonavir in Opioid‐Dependent Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(7). 863–874. 15 indexed citations
19.
Hendrix, Craig W., Mary Beth Wire, Yu Lou, et al.. (2004). Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Amprenavir in Opioid‐Dependent Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(9). 1110–1121. 26 indexed citations
20.
Martinez, Elizabeth. (1993). Beyond Black/white: The Racisms of Our Time. Social Justice A Journal of Crime Conflict & World Order. 20. 22. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026